Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion

Fig. 2

Representative genome images from the Integrated Genome Viewer (IGV) alterations for deletion of ALK exon 1–19, and fusion of ALK-DCTN1 demonstrating ALK and DCTN1 fusion found in the patient with inflammatory myofibroblastic tumor with myxoid features who had a response to ALK inhibitor based therapy

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us